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INTRODUCTION
That corticosteroids act on a large number of
cells in vivo and in vitro is a Well recognized
phenomenon (1—5). Lymphocyte control, stress
reactions, inflammatory responses, and myriad
other systemic functions are also affected
crucially by naturally occurring and synthetic
steroids (6—9). As there arc many target cells
for corticosteroid activity, so also have there
been many systems devised for ascertaining
the potency of these compounds. Correlations
between the test systems and the various phys-
iological functions they are measuring differ-
widely according to the in vivo organ and the
in vitro technique employed. A high degree of
correlation from an in vitro system to a
physiological one is most desirable, not only
because the ease and practicality of an in vitro
assay would simplify testing of compounds
destined for in vivo actions, but also because
the accessibility and isolation of the in vitro
system would make investigation of the basic
mechanisms involved a simpler and faster
matter. This is especially true in a system
sensitive to fractions of micrograms per milli-
liter of fluid, which cloesly mimics phys-
iological conditions.
The anti-inflammatory activity of corti-
costeroids is one of the important functions
of that group of compounds (1, 5, 10). Connec-
tive tissues respond to inflammatory stimuli
with a series of reactions which arc inhibited
by corticosteroids. At the cellular level, the
flbroblast is intimately concerned with the
process of inflammation, both as a manu-
facturer of connective tissue components and
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as the cell of origin or transformation for
many other cell types (10, 11). The flbroblast
can be grown, isolated from other connective
tissue components, as a monolayer on glass or
as a cell suspension. Various in vivo func-
tions of the flbroblast are preserved and can
be stimulated to action in vitro (11, 12) by
the same substances that act on it in vivo.
There is even a diurnal variation in numbers
of connective tissue flbroblasts that parallels
the diurnal differences in steroid output by
the organism (13). Therefore, it is not sur-
prising that fibroblasts react to steroids with
morphological changes that are similar in vivo
and in vitro (4, 10, 14, 15, 16), and that these
reactions are correlated with inflammatory
effects.
It is the purpose of this paper to elucidate
in detail a method for studying, in vitro, the
effects on fibroblasts of minute amounts of
cortieostcroids (from 0.0001 jig/ml to 10 tg/
ml).
MATERIALS AND METHODS
yibroblasts of clone 929, strain L, were grown as
monolayers in Eagle's minimum essential medium
(17) (Earle's balanced salt solution) containing
2 mM glutamine, 10% calf serum, 100 U/mI peni-
cillin, and 0.1 mg/mI streptomycin sulfate. On day
zero of the experimental period, 100,000 cells were
inoculated into roller tubes 18 X 150 mm, which
were filled with 5% CO2 in air, and sealed with
silicon rubber stoppers. Following a 24 hour
stationary period to allow cellular attachment to
glass, the tubes were rotated at ¼ revolution per
minute for an additional 4 days. Media were re-
newed on day 4, and cell counts performed on day
5. Removal of cells from glass surfaces was ac-
complished by thorough scraping with a rubber
policeman, after the old growth medium bad been
removed and 5 ml of fresh medium added. Sus-
pensions were vigorously pipetted 10 times to
minimize cell clumping.
Conditions for counting cells were standardized.
All tubes for one experiment were seeded from the
same reservoir, after cell population was estab-
lished by duplicate counts. A volume of 1.0 ml of
a 100,000 cells/mi suspension was used to seed each
tube.
Counts on cells subjected to experimental con-
ditions were performed in an electronic cell
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counter.5 The contents of each tube were diluted
to 20 ml with medium that was first analyzed for
background activity. Counts were conductcd at
machine settings which gave the best spread and
amplitude on size distribution plot, with windows
between 20 threshold units and infinity. The former
corresponded to thc low point in the trough sepa-
rating cellular debris from intact cells. Each tube
was counted twice to insure that there was no
block in the aperture tube of the counter nor
some other mechanical interference.
Substances whose effect on fibroblast growth
were to be tested, were dissolved in culture
medium and added to the cells at the time of
original subculture. Steroids were weighed on a
precision balance, and dissolved in absolute
methanol to give appropriate concentrations (100,
1, or 0.01 cg/ml). Aliguots of these solutions were
pipetted into 8 ounce prescription bottles to which
a propylene glycol-methanol mixture had been
added in such quantity as to give a final concen-
tration of 1 5cL propylene glycol/ml of finished
medium. The methanol was then volatilized under
a nitrogen stream in a water bath maintained at
less than 50° C, until only steroid dissolved in
propylene glycol remained. These bottles then re-
ceived 100 ml each of fresh complete culture
medium. Control tubes contained only propylene
glycol in the medium.
RESULTS
Statistical Analysis
A preliminary study was performed to de-
termine optimal seeding density and volume
for experiments. A number of tubes were inocu-
lated with 100,000 cells in 0.2 ml from a 1
ml pipette and in 1 and S ml volumes from
5 ml and 10 ml pipettes. Standard deviations
of cell counts on day 5 after seeding were
consistently lower among tubes seeded with 1
ml (S.D. 4—7%) and 5 ml (S.D. 1—2%) than
among those seeded with 0.2 ml (S.D. 9—20%).
Time considerations made the 5 ml inocula
impractical. Therefore, 1.0 ml was chosen as
the inoculum volume from all experiments. It
was known from previous week-long experi-
ments that a good growth of cells with con-
sistent and optimal sensitivity to steroids
could he obtained if 100,000 cells were allowed
to grow for 5 days in roller tubes (4).
As was mentioned earlier, two counts were
performed on each cell sample. Duplication on
the counter was very good, and standard de-
viations between two counts on the same sam-
ple were always (1.
To simplify calculations, both counts on
* Coulter Model B.
each tube were averaged, this value being used
as the true count for that sample. Repeated
determinations with the same sample indi-
cated that the counts followed a Poisson dis-
tribution, and based on Poisson statistics, it
was determined that an error less than 2%
could be attained with 95% confidence by
counting a total of 9600 cells per tube.
Let L be a sample count and S the vari-
ance of that count (18)
.02L

1.96 (SL)
.02L
 1.96%/L
\/L  98
L  9600
All counts were carried out to this level. More-
over, the 99% confidence level could be at-
tained by counting 16,000 cells, and in the
vast majority of cases, this level was reached.
Counts over 50,000 were avoided because they
necessitated progressively larger machine co-
incidence corrections.
Statistical analyses of the results obtained
by counting five tubes per treatment group
were performed by the analysis of variance
method (19, 20). Since the raw data did not
follow a normal distribution, logarithmic
transformations were employed to achieve this
end. Table I demonstrates the log-transformed
data on a typical experiment involving cells
treated with cortisol (4-pregncn 11fl,17a,21-
triol ,3,20-dione) and fluocinolone acetonide
(6a ,9a-difiuoro-11,8, 16a, 17a,21 -tetrahydroxy
pregnan-1-4-dicne 3,20 dione 16, 17-acetonide).
Bartlett's Test (20) was applied to determine
homogeneity of variances (8°), a prerequisite
for further statistical evaluation by the method
of analysis of variance. As pictured in Table
II, the analysis of variance was used to de-
termine whether there was a difference be-
tween treatments, significant regression, and
no deviation from parallelism. If these cri-
teria were met, the regression coefficient (5)
was determined and a fitted line constructed
on the appropriate graph (see Fig. 1). (The
criterion for curvature was not strictly ob-
served, as in this case, where there is signifi-
cant curvature, with P < .01.) This char-
acteristic is not crucial for the statistical
method. In the example, giving cortisol an as-
signed potency of 1:
(oortisol) = —0.2999
(fluocinolone) —. 02550
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TABLE I
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Example of raw data for a typical experiment
Logarithmic transformations of numbers of cells (divided by 1O) per tube, sum of cells per group
(BY) and variance per group (S2).
Control
Cortisol (5g/ml) Fluocinolone acetonide (,g/ml)
0.01 0.1 1.0 0.0001 0.001 0.01 0.1
1.974
1.810
1.784
1.837
1.885
Y9.290
8200056
1.987
1.897
2.042
1.912
1.869
9.698
0.0049
1.796
1.698
1.727
1.767
1.768
8.756
0.0015
1.438
1.296
1.305
1.352
1.308
6.699
0.0035
1.776
1.812
1.848
1.695
1.845
8.976
0.0040
1.637
1.495
1.459
1.515
1.516
7.622
0.0045
1.239
1.231
1.259
1.197
1.178
6.104
0.0011
1.124
1.006
0.937
1.064
1.101
5.232
0.0057
TABLE II
Summary of pertinent data for analysis of variance of a typical experiment
Source of Variation d.f. Sum of squares Mean square F P
Total
Within groups
Between groups
Control vs. treatment
Within treatments
Regression
Deviation from parallelism
Preparation
Curvature
39
32
7
1
6
1
1
1
3
3.890
0.123
3.767
0.509
3.257
2.511
0.0144
0.673
0.0596
0.0038
0.538
0.509
0.543
2.511
0.0144
0.673
0.0199
140.06
132.59
141.31
653.47
3.75
175.12
5.17
'
—
< .001
**
.01 — .001
Combined b = —0.2678
Index of significance g = 0.00588
Index of precision A = 0.232
Potency ratio = 351.2
Fiducial limits potency ratio
= 234.6-525.7
The visualization of these data is seen in
Figure 1. At least three concentrations of corti-
sol were included in each experiment to give
continuity between separate experiments.
Propylene Glycol
Earlier studies of growth curves conducted
over a 7-day period, established the lack of
fibroblast inhibition or stimulation by pro-
pylene glycol at 1 p1/mi of medium, the con-
centration used in all experiments (4, 6). Re-
sults of more recent dose-effect studies con-
ducted at the fifth day of culture growth,
were subjected to analysis of variance and the
0.0111 0.001 0.01
STEROID/mi OF MEDIUM
0.1 1.0
FoG. 1. Log-log plot of fibroblast growth under
the influence of cortisol and fluocmolone acetonide.
The lines are statistically fitted, with dose of ster-
oid on the abscissa and millions of cells on the
ordinate.
Hartley multiple range tests (20, 21). The
latter indicated there was no effect on fibro-
blast growth by 0.1, 0.2, 0.5, 1.0, or 2.0 jag of
propylene glycol/mi of medium (Fig. 2).
Growth was significantly depressed by all con-
centrations of propylene glycol above 5 ag/ml.
CELLS /10
PER TUBE
1.0
0.1 -
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CELLS/to6
PER TORE
2.8
2.4
2.0
1.6
1.2
0.8
2.4
FIG. 2. Semilogarithmic plot of fibroblast growth
under the influence of propylene glycol. Number
of cells on the ordinate are plotted against propy-
lene glycol concentration on the abscissa.
TABLE III
Summary of relative potencies and pertinent
statistical data on several
corticosteroids tested
Steroid Range
Indices
(A)
Cortisone*
Corticosterone
Cortisol
Prednisolone
Dexamethasone
Paramethasone
Triamcinolone ace-
tonide
Fluocinolone aceton-
ide
0.48
1.0
1.7
7.5
11.3
156
440
0.31—0.65
—
1.1—2.3
6.9—8.0
5.4—18.6
146—167
350—509
0.2
—
0.2
0.1
0.07
0.2
0.1
Range = lowest and highest determinations ob-
tained from separate experiments.
X = all modes of precision in systemic exper-
iments equal to or less than values
given.
* Cortisone as well as other li-ketocorticoste-
roids have no effect in the fibroblast assay method
(6).
Relative Potencies
Table III summarizes the relative potencies
of a number of naturally occurring and syn-
thetic steroids, The compounds are listed in
order of increasing activity as fibroblast in-
hibitors. when cortisol, the most potent nat-
urally occurring anti-inflammatory corticos-
teroid, is assigned a potency of 1, other
steroids can be numerically compared to it.
Cortisone is a growth stimulant in the fibro-
blast assay (6), and because growth under its
influence shows no regression, a relative po-
tency cannot be assigned to it. The fact that
cortisone does occasionally exhibit anti-in-
flammatory action in vivo is explained by its
biotransformation to cortisol (21, 22) which
is minimal in this isolated tissue culture sys-
tem (6). In the second paper of this series the
relationship between this assay system and
others will be discussed.
CONcLUSIONS
The finding that the behavior of a pure cell
line in an isolated system is analogous in
some respects to its behavior in vivo is a
useful one. The method presented here is a
simple and accurate means to elucidate struc-
ture activity relationships, steroid potencies,
and cell metabolic behavior (4, 6). As an
assay system, it is an excellent tool for analyz-
ing corticosteroid effects by regression analy-
sis. The index of precision (A = 0.232 in the
example given) is generally between 0.1 and
0.3, which is indicative of a consistently
precise bioassay system. Systems giving vari-
ances small enough to produce precision in-
dices below 0.1 are extremely rare, and require
sample sizes greatly in excess of the five uti-
lized in this system. The remarkable repro-
ducibility of data in the tissue culture fibro-
blast assay is reflected in repetitions of
potency ratios and consistency of dose-effect
curves. Despite this good reproducibility, it
must still be remembered that the assay is
dependent on the tissue culture system, and
therefore all the attendant possibilities for
contamination (bacteria, virus, foreign cell
line), altered growth due to changes in media
lots, and spontaneous mutations. Structure-ac-
tivity relationships have been shown to hold
constant in this system in demonstrating the
importance of the 11/3- and 17a-hydroxyl
groups, 16, 17-acetonide structure, and 6a- and
9a-fluorine substitutions (4). Its anti-inflam-
matory assay potential is well illustrated in
Table III.
The rank order of potency for topical anti-
inflammatory activity of steroids increases from
cortisol, through prednisolone (1,4 pregnadiene
11/3, l7a ,21-triol ,3,20-dionl), dexamethasone
(9a-fluoro 16a-methyl-11/9, l7ot, 21-trihydroxy
CONTROL
0.2 0.5 1.0 2.0 5.0 10.0 15.0 25.0
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pregna-1 , 4-diene-3 ,20-dione), paramethasone
(6a-fluoro 16a-methyl 11/3, 17a, 21-trihydroxy
pregnan-l,4-diene 3,20-dione), and triamcinolone
acetonide (9a-fluoro-1 1/3, 16a, 17a , 21-tetrahy-
droxy-pregnan-1 ,4-diene 3, 20-dione 16, 17-acet-
onide), to the highly active compound fluocino-
lone acetonide (5, 23, 24). This order finds a
direct parallel in the ranking of steroid activity
by the fibroblast assay method.
An assay method, to be effective, must func-
tion in the physiological range. The fibroblast
assay method is sensitive to a concentration
of fluocinolone acetonide of 0.0005 fig/ml
(approximately 10-' M), and a concentration
of cortisol of 0.1 tg/ml (approximately 3 x
10 M), well within physiological limits. Any
steroid, when given in large enough quantities,
will act as an indiscriminate cellular poison,
and the tissue culture fibroblast will respond
with diminished growth and then death to
high concentrations (25 to 100 pg/ml or ap-
proximately 10-' M) of even the most in-
active anti-inflammatory steroid (4).
Although the direct relationship that exists
between fibroblast cell division and inflam-
mation is not understood at this time, there
is a correlation of steroid effects in these two
processes.
Finally, the steroid biotransformation dem-
onstrated in the presence of these cells (22, 25)
and their potential as precursors of many
other cell types combined with their ability
to perform many of their in vivo functions
in vitro, make this system a highly flexible
and potentially unlimited source of informa-
tion concerning the mechanism of action of
anti-inflammatory steroids.
SUMMARY
Fibroblasts in a tissue culture system closely
mimic, in their reaction to various corti-
costeroids, the response of inflammcd tissue
in vivo. When concentrations of steroids in
the physiological range (from 0.0001 to 10
tg/ml of medium) are added to strain L
fibroblasts, these cells respond with decreased
growth and morphological changes similar to
those exhibited by connective tissue fibroblasts
under corticosteroid influence. Details of the
in vitro assay method are presented, together
with information concerning the statistical
treatment of the data obtained. Relative po-
tcncies of various naturally occurring and syn-
thetic steroids compared to cortisol (potency
= 1), determined in this assay system, range
from 0.48 for corticosterone, 1.7 for prcdniso-
lone, 11.3 for paramethasone, 7.5 for dexa-
methasonc, 156 for triamcinolonc acctonidc,
and 440 for fluocinolone acetonide. These fig-
ures correlate well with the relative activities
of these steroids found in clinical trials in
topical inflammatory conditions.
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